FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to gynaecology, and can be used for female contraception. Inventions include methods of female contraception. That is ensured by the multiple administration of a dosage form started in a day of month marked either by 'n+3', or 'n+4', or 'n+5', or 'n+6' date and taken out in a day marked by 'n' number of the next month for at least two cycles where 'n' is a date either within 1 to 25, or 1 to 24, or 1 to 23, or 1 to 22 respectively. Also, the inventions involve female contraception kits containing at least two dosage forms and patient information leaflets according to the declared modes of contraception. Besides, the inventions comprise a dosing regimen reminder system adjusted in such a manner that it allows to choose one specific date either within 1 to 25, or within 1 to 24, or within 1 to 23, or within 1 to 22 regardless of a month, as a date when the dosage form is always taken out and a date when a new dosage form shall be used either through three, or through four, or through five, or through six days thereafter respectively.
EFFECT: inventions provide convenient administration of contraceptives with maintained efficacy of contraception and its increase in certain cases.
1 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
ESTROGEN (PROGESTIN)-ANITOPROGESTIN METHOD OF PERORAL CONTRACEPTION AND MENSTRUATION CONTROL, PHARMACEUTICAL COMPOSITION, AND ASSEMBLY OF DRUGS | 1993 |
|
RU2127112C1 |
THREE-PHASE ORAL CONTRACEPTIVE | 1999 |
|
RU2225207C2 |
COMBINED PREPARATION FOR CONTRACEPTION, PHARMACEUTICAL CONTAINER FOR CONTRACEPTION | 1994 |
|
RU2122854C1 |
CONTRACEPTION METHOD FOR BEING USED BY WOMEN OF REPRODUCTIVE PERIOD NOT ACCESSING PREMENOPAUSAL PERIOD | 1994 |
|
RU2169567C2 |
APPLICATION OF ANTIPROGESTAGENS IN COMBINED THERAPY | 2000 |
|
RU2234321C2 |
USE OF NOVEL ETHONOGESTREL ESTERS | 2003 |
|
RU2322986C2 |
SYSTEM OF MEDICATION DELIVERY | 2008 |
|
RU2488369C2 |
ORAL CONTRACEPTIVES FOR PREVENTION PREGNANCY AND REDUCTION OF PREMENSTRUAL SYMPTOMATOLOGY | 2002 |
|
RU2351339C2 |
MIXED PREPARATION BASED ON NATURAL ESTROGENS FOR CONTRACEPTION | 1996 |
|
RU2113849C1 |
METHOD FOR REDUCING RISK TO ACQUIRE MAMMARY GLAND CARCINOMA | 1992 |
|
RU2067001C1 |
Authors
Dates
2011-01-10—Published
2006-06-16—Filed